PT  - JOURNAL ARTICLE
AU  - Srivastava, Minu
AU  - Murriel, Christopher
AU  - Yun, Rui
AU  - Mayes, Erin
AU  - Jie, Hyun-Bae
AU  - Axelrod, Fumiko
AU  - Xie, Ming-Hong
AU  - Bentley, Trevor
AU  - Cancilla, Belinda
AU  - Tam, Raymond
AU  - O'Young, Gilbert
AU  - Kapoun, Ann
AU  - Lewicki, John
AU  - Hoey, Tim
AU  - Gurney, Austin
AU  - Inkyung, Park Angie
TI  - Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses
AID  - 10.1186/2051-1426-3-S2-P373
DP  - 2015 Dec 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - P373
VI  - 3
IP  - Suppl 2
4099  - http://jitc.bmj.com/content/3/Suppl_2/P373.short
4100  - http://jitc.bmj.com/content/3/Suppl_2/P373.full
SO  - J Immunother Cancer2015 Dec 01; 3